Skip to main content
Top

Cellular Oncology

Issue 4/2020

Content (14 Articles)

Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles

Meysam Yousefi, Sadegh Dehghani, Rahim Nosrati, Mahmoud Ghanei, Arash Salmaninejad, Sara Rajaie, Malihe Hasanzadeh, Alireza Pasdar

Ovarian Cancer Original paper

The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary

Smarakan Sneha, Rohit P. Nagare, Chirukandath Sidhanth, Syama Krishnapriya, Manoj Garg, Balaji Ramachandran, Kanchan Murhekar, Shirley Sundersingh, Trivadi S. Ganesan

Lung Cancer Original paper

PFKP is highly expressed in lung cancer and regulates glucose metabolism

Jianfei Shen, Zixian Jin, Haiyan Lv, Ke Jin, Kangberee Jonas, Chengchu Zhu, Baofu Chen

Epigenetics Original paper

Overexpression of Sal-like protein 4 in head and neck cancer: epigenetic effects and clinical correlations

Kiyoshi Misawa, Yuki Misawa, Masato Mima, Satoshi Yamada, Atsushi Imai, Daiki Mochizuki, Takuya Nakagawa, Tomoya Kurokawa, Shiori Endo, Hideya Kawasaki, John Chadwick. Brenner, Hiroyuki Mineta

Lung Cancer Original paper

IL-17A and IL-17F orchestrate macrophages to promote lung cancer

Nathalia Ferreira, Inês Mesquita, Fátima Baltazar, Ricardo Silvestre, Sara Granja

Metastasis Original paper

Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level

Jing Mo, Xiulan Zhao, Xueyi Dong, Tieju Liu, Nan Zhao, Danfang Zhang, Wei Wang, Yanhui Zhang, Baocun Sun

Metastasis Original paper

The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis

Yangjiong Xiao, Yang Yu, Pengcheng Jiang, Yuhong Li, Chao Wang, Rong Zhang

Original paper

Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma

Shuangshuang Mao, Yuan Li, Zhiliang Lu, Yun Che, Jianbing Huang, Yuanyuan Lei, Yalong Wang, Xinfeng Wang, Chengming Liu, Sufei Zheng, Ning Li, Jiagen Li, Nan Sun, Jie He

Original paper

A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma

Li Shen, Min Xia, Xinzhou Deng, Qing Ke, Chuanyi Zhang, Feng Peng, Xiaoxia Dong, Zhiguo Luo

Breast Cancer Original paper

Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications

Saimul Islam, Hemantika Dasgupta, Mukta Basu, Anup Roy, Neyaz Alam, Susanta Roychoudhury, Chinmay Kumar Panda

Report

Zebularine-induced myeloma cell death is accompanied by decreased c-Myc expression

Patryk Krzeminski, Ramón García-Sanz, Norma C. Gutiérrez

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine